Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2–16 Years
Crossref DOI link: https://doi.org/10.1007/s13300-016-0196-5
Published Online: 2016-09-06
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thalange, Nandu
Bereket, Abdullah
Jensen, Lisbeth Bjerring
Hiort, Line Conradsen
Peterkova, Valentina
Funding for this research was provided by:
Novo Nordisk
Text and Data Mining valid from 2016-09-06
Article History
Received: 17 June 2016
First Online: 6 September 2016